Arsenic induces apoptosis through a c-Jun NH2-terminal kinase- dependent, p53-independent pathway

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3053-3058

  Huang, Chuanshu ^a   Ma, Wei Ya ^a   Li, Jingxia ^a   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER; CANCER CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

ANIMALS; APOPTOSIS; ARSENIC; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL ADHESION; CELL LINE; DNA FRAGMENTATION; EPIDERMAL GROWTH FACTOR; GENES, REPORTER; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUCIFERASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033168034     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Nriagu, J. O. Arsenic in the Environment, Part II. Human Health and Ecosystem Effects. New York: Wiley, 1994.
2. Sommers, S. C., and McManus, R. G. Multiple arsenical cancers of skin and internal organs. Cancer (Phila.), 6: 347-359, 1953.
3. Chen, C-J., Chuang, Y-C., Lin, T-M., and Wu, H-Y. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res., 45: 5895-5899, 1985.
4. Smith, A. H., Hopenhayn-Rich, C., Bates, M. N., Goeden, H. M., Hertz-Picciotto, P., Duggan, H. M., Wood, R., Kornett, M. J., and Smith, M. T. Cancer risks from arsenic in drinking water. Environ. Health Perspect., 97: 259-267, 1992.
5. Bainbridge, W. S. The Cancer Problem, p. 271. New York: Macmillan, 1914.
6. Forkner, C., and McNair-Scott, T. F. Arsenic as a therapeutic agent in chronic myeloid leukemia. J. Am. Med. Assoc., 97: 305, 1931.
7. Kandel, E. V., and Leroy, G. V. Chronic arsenical poisoning during the treatment of chronic myeloid leukemia. Arch. Intern. Med., 60: 846-866, 1937.
8. Konig, A., Wrazel, L., Warrel, R. P., Jr., Rivi, R., Pandolfi, P. P., Jakubowski, A., and Gabrilcve, J. L. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood, 90: 562-570, 1997.
9. 3 exerts dose-dependent dual effects on APL cells. Blood, 89: 3345-3353, 1997.
10. 4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-Raα/PML proteins. Blood, 88: 1052-1061, 1996.
11. Huang, C., Ma, W-Y., Li, J., Goranson, A., and Dong, Z. Requirement of Erks, but not JNKs, for arsenite-induced cell transformation. J. Biol. Chem., 274: 14595-14601, 1999.
12. Ludwig, S. A., Hoffmeyer, A., Goebeler, M., Kilian, K., Hafner, H., Neufeld, B., Han, J., and Rapp, U. R. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J. Biol. Chem., 273: 1917-1922, 1998.
13. Look, A. T. Arsenic and apoptosis in the treatment of acute promyelocytic leukemia. J. Natl. Cancer Inst., 90: 86-88, 1998.
14. Shao, W., Fanelli, M., Ferrara, F. F., Riccioni, R., Rosenauer, A., Davison, K., Lamph, W. W., Waxman, S., Pelicci, P. G., Lo Coco, F., Avvisati, G., Testa, U., Peschle, C., Gambacorti-Passerini, C., Nervi, C., and Miller, W. H., Jr. Arsenic trioxide as an inducer of apoptosis and loss of PMU/RARα protein in acute promyelocytic leukemia cells. J. Natl. Cancer. Inst., 90: 124-133, 1998.
15. + cells. Mol. Cell. Biol., 16: 6427-6435, 1996.
16. Huang, C., Ma, W-Y., Li, J., Hecht, S., and Dong, Z. Essential role of p53 in phenethyl isothiocyanate-induced apoptosis. Cancer Res., 58: 4102-4106, 1998.
17. Harvey, M., Sands, A. T., Weiss, R. S., Hegi, M. E., Wiseman, R. W., Pantazis, P., Giovanella, B. C., Tainsky, M. A., Bradley, A., and Donehower, L. A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene, 8: 2457-2467, 1993.
18. Huang, C., Schmid, P. C., Ma, W-Y., Schmid, H. H. O., and Dong, Z. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein-1 activation. J. Biol. Chem., 272: 4187-4194, 1997.
19. Huang, C., Ma, W-Y., Ryan, C. A., and Dong, Z. Proteinase inhibitors I and II from potatoes specifically block UV-induced activator protein-1 activation through a pathway that is independent of extracellular signal-regulated kinases, c-Jun N-terminal kinases, and P38 kinase. Proc. Natl. Acad. Sci. USA, 94: 11957-11962, 1997.
20. Huang, C., Ma, W-Y., Goranson, A., and Dong, Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis, 20: 237-242, 1999.
21. Huang, C., Ma, W-Y., Ding, M., Bowden, G. T., and Dong, Z. Direct evidence for an important role of sphingomyelinase in ultraviolet-induced activation of c-Jun N-terminal kinase. J. Biol. Chem., 272: 27753-27757, 1997.
22. Amundson, S. A., Myers, T. G., and Fornace, A. J., Jr. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene, 17: 3287-3299, 1998.
23. Basu, S., and Kolesnick, R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene, 17: 3277-3285, 1998.
24. Dragovich, T., Rudin, C. M., and Thompson, C. R. Signal transduction pathways that regulate cell survival and cell death. Oncogene, 17: 3207-3213, 1998.
25. Merritt, A. J., Potten, C. S., Kemp, C. J., Hickman, J. A., Balmain, M., Lane, D. P., and Hall, P. A. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res., 54: 614-617, 1994.
26. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer drugs. Cell, 74: 957-967, 1993.
27. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
28. Ochi, T., Nakajima, F., Sakurai, T., Kaise, T., and Oya-Ohta, Y. Dimethylarsinic acid causes apoptosis in HL-60 cells via interaction with glutathione. Arch. Toxicol., 70: 815-821, 1996.
29. Hollstein, M., Rice, K., Greenbalt, M. S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorenson, B., Montesano, R., and Harris, C. C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 22: 3551-3555, 1994.
30. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992.
31. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., and Friend, S. H. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.
32. Donehower, L. A., Harvey, M., Vogel, H., McArthur, M. J., Montgomery, C. A. J., Park, S. H., Thompson, T., Ford, R. J., and Bradley, A. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinog., 14: 16-22, 1995.
33. Lavigueur, A., Maltby, V., Mock, D., Rossant, J., Pawson, T., and Berstein, A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol., 9: 3982-3991, 1989.
34. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
35. Ziegler, A., Jonason, A. S., Leffell, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
36. 3 gene. Nature (Lond.), 389: 865-870, 1997.
37. Chen, Y. R., Wang, X. P., Templeton, D., Davis, R. J., and Tan, T. H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem., 271: 31929-31936, 1996.
38. Lenczowski, J. M., Dominguez, L., Eder, A. M., King, L. B., Zacharchuk, C. M., and Ashwell, J. D. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol., 17: 170-181, 1997.
39. Goillot, E., Raingeaud, J., Ranger, A., Tepper, R. I., Davis, R. J., Harlow, E., and Sanchez, I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA, 94: 3302-3307, 1997.
40. Yeh, W. C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J., Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D., and Mak, T. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity, 7: 715-725, 1997.
41. Miller, M., Wilder, S., Bannasch, D., Lehlback, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., and Krammer, P. H. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med., 188: 2033-2045, 1998.
42. Eldeiry, W. S. The p53 pathway and cancer therapy. Cancer J., 11: 229-236, 1998.
43. Husain, A., Rosales, N., Schwartz, G. K., Spriggs, D. R. Lisofylline sensitizes p53 mutant human ovarian carcinoma cells to the cytotoxic effects of cis-diamminedichloroplatinum (II). Gynecol. Oncol., 70: 17-22, 1998.